Table of Content

1 Therapeutic Vaccines Market Introduction and Overview
1.1 Therapeutic Vaccines Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Therapeutic Vaccines Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Therapeutic Vaccines Revenue and Market Share by Type
3 Global Therapeutic Vaccines Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Therapeutic Vaccines Revenue Market Share by Application (2019-2024)
4 Global Market Growth Trends Analysis
4.1 Global Therapeutic Vaccines Market Size (2019-2024)
4.2 Therapeutic Vaccines Growth Trends Analysis by Regions
4.2.1 Therapeutic Vaccines Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Therapeutic Vaccines Historic Revenue Market Size by Regions (2019-2024)
4.2.3 North America Therapeutic Vaccines Market Size (2019-2024)
4.2.4 Europe Therapeutic Vaccines Market Size (2019-2024)
4.2.5 Asia-Pacific Therapeutic Vaccines Market Size (2019-2024)
4.2.6 Latin America Therapeutic Vaccines Market Size (2019-2024)
4.2.7 Middle East & Africa Therapeutic Vaccines Market Size (2019-2024)
5 North America
5.1 North America Therapeutic Vaccines Revenue by Countries
5.1.1 North America Therapeutic Vaccines Revenue by Countries (2019-2024)
5.2 North America Therapeutic Vaccines Revenue by Types
5.3 North America Therapeutic Vaccines Revenue by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Therapeutic Vaccines Revenue by Countries
6.1.1 Asia Pacific Therapeutic Vaccines Revenue by Countries (2019-2024)
6.2 Asia Pacific Therapeutic Vaccines Revenue by Types
6.3 Asia Pacific Therapeutic Vaccines Revenue by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Therapeutic Vaccines Revenue by Countries
7.1.1 Europe Therapeutic Vaccines Revenue by Countries (2019-2024)
7.2 Europe Therapeutic Vaccines Revenue by Types
7.3 Europe Therapeutic Vaccines Revenue by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Therapeutic Vaccines Revenue by Countries
8.1.1 Latin America Therapeutic Vaccines Revenue by Countries (2019-2024)
8.2 Latin America Therapeutic Vaccines Revenue by Types
8.3 Latin America Therapeutic Vaccines Revenue by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Therapeutic Vaccines Revenue by Countries
9.1.1 Middle East & Africa Therapeutic Vaccines Revenue by Countries (2019-2024)
9.2 Middle East & Africa Therapeutic Vaccines Revenue by Types
9.3 Middle East & Africa Therapeutic Vaccines Revenue by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Therapeutic Vaccines Market Competition, by Players
10.1 Global Therapeutic Vaccines Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Therapeutic Vaccines Players Market Share in 2023
10.2.2 Top 6 Therapeutic Vaccines Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Therapeutic Vaccines Players Head Office, Business Provided
10.4 Therapeutic Vaccines Mergers & Acquisitions
10.5 Therapeutic Vaccines New Entrants and Expansion Plans
11 Players Profiles11.1 Valeant Pharmaceuticals
11.1.1 Valeant Pharmaceuticals Company Profile
11.1.2 Therapeutic Vaccines Product Overview
11.1.3 Valeant Pharmaceuticals Therapeutic Vaccines Market Performance (2019-2024)
11.1.4 Valeant Pharmaceuticals Business Overview
11.1.5 Recent Developments and Plans
11.2 BioVex Inc
11.2.1 BioVex Inc Company Profile
11.2.2 Therapeutic Vaccines Product Overview
11.2.3 BioVex Inc Therapeutic Vaccines Market Performance (2019-2024)
11.2.4 BioVex Inc Business Overview
11.2.5 Recent Developments and Plans
11.3 Inovio Pharmaceuticals Inc
11.3.1 Inovio Pharmaceuticals Inc Company Profile
11.3.2 Therapeutic Vaccines Product Overview
11.3.3 Inovio Pharmaceuticals Inc Therapeutic Vaccines Market Performance (2019-2024)
11.3.4 Inovio Pharmaceuticals Inc Business Overview
11.3.5 Recent Developments and Plans
11.4 Immunocellular Therapeutics Ltd
11.4.1 Immunocellular Therapeutics Ltd Company Profile
11.4.2 Therapeutic Vaccines Product Overview
11.4.3 Immunocellular Therapeutics Ltd Therapeutic Vaccines Market Performance (2019-2024)
11.4.4 Immunocellular Therapeutics Ltd Business Overview
11.4.5 Recent Developments and Plans
11.5 Agenus Inc
11.5.1 Agenus Inc Company Profile
11.5.2 Therapeutic Vaccines Product Overview
11.5.3 Agenus Inc Therapeutic Vaccines Market Performance (2019-2024)
11.5.4 Agenus Inc Business Overview
11.5.5 Recent Developments and Plans
11.6 GlaxoSmithKline plc
11.6.1 GlaxoSmithKline plc Company Profile
11.6.2 Therapeutic Vaccines Product Overview
11.6.3 GlaxoSmithKline plc Therapeutic Vaccines Market Performance (2019-2024)
11.6.4 GlaxoSmithKline plc Business Overview
11.6.5 Recent Developments and Plans
11.7 Pfizer Inc.
11.7.1 Pfizer Inc. Company Profile
11.7.2 Therapeutic Vaccines Product Overview
11.7.3 Pfizer Inc. Therapeutic Vaccines Market Performance (2019-2024)
11.7.4 Pfizer Inc. Business Overview
11.7.5 Recent Developments and Plans
11.8 Novartis AG
11.8.1 Novartis AG Company Profile
11.8.2 Therapeutic Vaccines Product Overview
11.8.3 Novartis AG Therapeutic Vaccines Market Performance (2019-2024)
11.8.4 Novartis AG Business Overview
11.8.5 Recent Developments and Plans
11.9 Argos Therapeutics
11.9.1 Argos Therapeutics Company Profile
11.9.2 Therapeutic Vaccines Product Overview
11.9.3 Argos Therapeutics Therapeutic Vaccines Market Performance (2019-2024)
11.9.4 Argos Therapeutics Business Overview
11.9.5 Recent Developments and Plans
11.10 Bavarian Nordic
11.10.1 Bavarian Nordic Company Profile
11.10.2 Therapeutic Vaccines Product Overview
11.10.3 Bavarian Nordic Therapeutic Vaccines Market Performance (2019-2024)
11.10.4 Bavarian Nordic Business Overview
11.10.5 Recent Developments and Plans
11.11 Transgene
11.11.1 Transgene Company Profile
11.11.2 Therapeutic Vaccines Product Overview
11.11.3 Transgene Therapeutic Vaccines Market Performance (2019-2024)
11.11.4 Transgene Business Overview
11.11.5 Recent Developments and Plans
11.12 Galena Biopharma and Vaccinogen Inc
11.12.1 Galena Biopharma and Vaccinogen Inc Company Profile
11.12.2 Therapeutic Vaccines Product Overview
11.12.3 Galena Biopharma and Vaccinogen Inc Therapeutic Vaccines Market Performance (2019-2024)
11.12.4 Galena Biopharma and Vaccinogen Inc Business Overview
11.12.5 Recent Developments and Plans
12 Global Therapeutic Vaccines Forecast Market Analysis by Type
12.1 Global Therapeutic Vaccines Revenue Market Forecast by Type (2024-2030)
13 Global Therapeutic Vaccines Forecast Market Analysis by Application
13.1 Therapeutic Vaccines Revenue Market Forecast by Application (2024-2030)
14 Global Market Growth Forecast Analysis
14.1 Global Therapeutic Vaccines Forecast Market Size (2024-2030)
14.2 Therapeutic Vaccines Growth Trends Forecast Analysis by Regions
14.2.1 Therapeutic Vaccines Revenue Forecast Market Size by Regions (2024-2030)
14.2.2 North America Therapeutic Vaccines Forecast Market Size (2024-2030)
14.2.3 Europe Therapeutic Vaccines Forecast Market Size (2024-2030)
14.2.4 Asia-Pacific Therapeutic Vaccines Forecast Market Size (2024-2030)
14.2.5 Latin America Therapeutic Vaccines Forecast Market Size (2024-2030)
14.2.6 Middle East & Africa Therapeutic Vaccines Forecast Market Size (2024-2030)
15 Therapeutic Vaccines Industry Dynamic Analysis
15.1 Therapeutic Vaccines Market Trends Analysis
15.2 Therapeutic Vaccines Market Drivers Analysis
15.3 Therapeutic Vaccines Market Challenges Analysis
15.4 Therapeutic Vaccines Market Restraints Analysis